moxalactam has been researched along with Streptococcal Infections in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 8 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abbruzzese, JL; Laskin, OL; Lipsky, JJ; McGaughey, MD; Rocco, LE; Skubitz, KM | 1 |
Cherubin, CE; Corrado, ML; Landesman, SH; Sierra, MF | 1 |
Knothe, H | 1 |
Alexander-Williams, J; Ambrose, NS; Keighley, MR | 1 |
Gilbert, DN; Thorp, GR | 1 |
Anhalt, JP; Cockerill, FR; Edson, RS; Geraci, JE; Henry, NK; Hermans, PE; Keys, TF; Muller, SM; Rosenblatt, JE; Wilson, WR | 1 |
Smith, AL | 1 |
Danziger, LH; Ferron, JL; Gauderer, MW; Gordon, N; Hau, T; Stellato, TA | 1 |
2 review(s) available for moxalactam and Streptococcal Infections
Article | Year |
---|---|
Neonatal bacterial infection.
Topics: Antigens; B-Lymphocytes; Bacterial Infections; Chemotaxis, Leukocyte; Complement System Proteins; Cross Infection; Digestive System; Escherichia coli Infections; Female; Gram-Negative Bacteria; Humans; Immunoglobulin G; Immunoglobulin M; Infant, Newborn; Maternal-Fetal Exchange; Meningitis; Methicillin; Moxalactam; Neutrophils; Penicillin G; Permeability; Phagocytosis; Pregnancy; Sepsis; Streptococcal Infections; T-Lymphocytes | 1982 |
Moxalactam vs tobramycin-clindamycin. A randomized trial in secondary peritonitis.
Topics: Abscess; Adolescent; Adult; Bacteroides Infections; Clindamycin; Clinical Trials as Topic; Combined Modality Therapy; Drug Therapy, Combination; Escherichia coli Infections; Humans; Hypoprothrombinemias; Infant, Newborn; Middle Aged; Moxalactam; Peritonitis; Premedication; Prospective Studies; Random Allocation; Sepsis; Streptococcal Infections; Surgical Wound Infection; Tobramycin | 1988 |
3 trial(s) available for moxalactam and Streptococcal Infections
Article | Year |
---|---|
Prospective randomized double-blind comparison of moxalactam and tobramycin in treatment of urinary tract infections.
Topics: Adult; Anti-Bacterial Agents; Cephalosporins; Cephamycins; Clinical Trials as Topic; Double-Blind Method; Female; Fever; Humans; Male; Middle Aged; Moxalactam; Prospective Studies; Random Allocation; Streptococcal Infections; Tobramycin; Urinary Tract Infections | 1983 |
Audit of sepsis in operations for inflammatory bowel disease.
Topics: Abscess; Adult; Colitis, Ulcerative; Crohn Disease; Female; Gentamicins; Humans; Male; Metronidazole; Mezlocillin; Middle Aged; Moxalactam; Prospective Studies; Streptococcal Infections; Surgical Wound Infection | 1984 |
Moxalactam vs tobramycin-clindamycin. A randomized trial in secondary peritonitis.
Topics: Abscess; Adolescent; Adult; Bacteroides Infections; Clindamycin; Clinical Trials as Topic; Combined Modality Therapy; Drug Therapy, Combination; Escherichia coli Infections; Humans; Hypoprothrombinemias; Infant, Newborn; Middle Aged; Moxalactam; Peritonitis; Premedication; Prospective Studies; Random Allocation; Sepsis; Streptococcal Infections; Surgical Wound Infection; Tobramycin | 1988 |
4 other study(ies) available for moxalactam and Streptococcal Infections
Article | Year |
---|---|
Activity of moxalactam and cefotaxime alone and in combination with ampicillin or penicillin against group B streptococci.
Topics: Ampicillin; Cefotaxime; Cephalosporins; Cephamycins; Drug Synergism; Humans; Moxalactam; Penicillin G; Penicillin Resistance; Streptococcal Infections; Streptococcus agalactiae | 1981 |
[In-vitro activity of cefotaxime].
Topics: Cefotaxime; Cefoxitin; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Moxalactam; Penicillin Resistance; Penicillins; Streptococcal Infections; Streptococcus | 1983 |
Progression of group A streptococcal necrotizing fasciitis during moxalactam therapy.
Topics: Aged; Fasciitis; Humans; Male; Moxalactam; Necrosis; Streptococcal Infections | 1984 |
Empiric therapy with moxalactam alone in patients with bacteremia.
Topics: Abdomen; Abscess; Adolescent; Adult; Aged; Bacteria; Combined Modality Therapy; Costs and Cost Analysis; Drug Evaluation; Drug Resistance, Microbial; Female; Follow-Up Studies; Humans; Infusions, Parenteral; Male; Middle Aged; Moxalactam; Sepsis; Streptococcal Infections; Time Factors | 1984 |